RA TV: Vaccines versus variants
RA TV
Scientific members of the RA Capital team lead periodic, public, interactive, webinar-style discussions on Zoom. Learn more here.
July 8, 2021
Listen in as five of RA Capital’s TechAtlas Associates - Michael Gillespie, Jonathan Pritz, Katie Terranova, Shan Shan Wang, and Peter Balogh - convene on camera to discuss recent Covid-19 news.
Topics:
Understanding the Delta variant (How effective is each vaccine against Delta? If you’re vaccinated, should you still wear a mask?)
Reviewing Novavax’s and CureVac’s recent Phase 3 data (With 3-4 vaccines already approved, where might additional vaccines fit in? What can CureVac’s data teach us about mRNA technology?)
Why issues of tolerability may tip the scales (for adjuvants and combination vaccines)
How concerned should we be about the potential myocarditis risk observed in some young adults post-second dose?
Why should we continue to care about therapeutics when vaccines are working well?
Join the RA TV crew live on Zoom every month by registering here or watch past episodes of RA TV on the RA Capital website.
—
RA Capital is a registered investment adviser. This material is not intended, and should not be construed as, investment advice or recommendation to invest in any security. Likewise, this material is not intended as a solicitation to invest in any RA Capital product or service.